Published in Zh Mikrobiol Epidemiol Immunobiol on February 01, 1979
Structure of the Escherichia coli response regulator NarL. Biochemistry (1996) 3.19
The Bacillus subtilis hemAXCDBL gene cluster, which encodes enzymes of the biosynthetic pathway from glutamate to uroporphyrinogen III. J Bacteriol (1991) 1.76
Cloning and characterization of the hemA region of the Bacillus subtilis chromosome. J Bacteriol (1990) 1.37
NarL dimerization? Suggestive evidence from a new crystal form. Biochemistry (1998) 1.30
Recommendations for the forensic diagnosis of sex and age from skeletons. Homo (2007) 1.15
Regulation of narK gene expression in Escherichia coli in response to anaerobiosis, nitrate, iron, and molybdenum. J Bacteriol (1992) 1.11
The NarX and NarQ sensor-transmitter proteins of Escherichia coli each require two conserved histidines for nitrate-dependent signal transduction to NarL. J Bacteriol (1995) 1.09
Crystal structures of a novel ferric reductase from the hyperthermophilic archaeon Archaeoglobus fulgidus and its complex with NADP+. Structure (2001) 1.08
Site-directed mutagenesis of conserved cysteine residues in Escherichia coli fumarate reductase: modification of the spectroscopic and electrochemical properties of the [2Fe-2S] cluster. Proc Natl Acad Sci U S A (1990) 1.04
Cloning and nucleotide sequence of the psrA gene of Wolinella succinogenes polysulphide reductase. Eur J Biochem (1992) 1.03
[3Fe-4S] to [4Fe-4S] cluster conversion in Escherichia coli fumarate reductase by site-directed mutagenesis. Biochemistry (1992) 0.98
Properties of a thermostable nitrate reductase from the hyperthermophilic archaeon Pyrobaculum aerophilum. J Bacteriol (2001) 0.98
Lipopolysaccharides of Rhizobium etli strain G12 act in potato roots as an inducing agent of systemic resistance to infection by the cyst nematode Globodera pallida. Appl Environ Microbiol (2000) 0.98
Comparison between the nitric oxide reductase family and its aerobic relatives, the cytochrome oxidases. Biochem Soc Trans (2002) 0.94
Structure of alanine dehydrogenase from Archaeoglobus: active site analysis and relation to bacterial cyclodeaminases and mammalian mu crystallin. J Mol Biol (2004) 0.93
Analyzing your complexes: structure of the quinol-fumarate reductase respiratory complex. Curr Opin Struct Biol (2000) 0.93
A novel copper A containing menaquinol NO reductase from Bacillus azotoformans. Biochemistry (2001) 0.92
An Escherichia coli mutant quinol:fumarate reductase contains an EPR-detectable semiquinone stabilized at the proximal quinone-binding site. J Biol Chem (1999) 0.90
Effect of cysteine to serine mutations on the properties of the [4Fe-4S] center in Escherichia coli fumarate reductase. Biochemistry (1995) 0.89
Early treatment of unilateral posterior crossbite in children with bilaterally contracted maxillae. Eur J Orthod (1984) 0.88
Identification and characterization of a novel ferric reductase from the hyperthermophilic Archaeon Archaeoglobus fulgidus. J Biol Chem (1999) 0.87
Evidence for non-cysteinyl coordination of the [2Fe-2S] cluster in Escherichia coli succinate dehydrogenase. FEBS Lett (1992) 0.87
Aerobic inactivation of fumarate reductase from Escherichia coli by mutation of the [3Fe-4S]-quinone binding domain. J Bacteriol (1995) 0.87
[On some problems of paper chromatographic amino acid analysis of natural materials]. Pharmazie (1967) 0.87
Sequence of mature phosphoglycerate kinase from spinach chloroplasts. Plant Physiol (1993) 0.79
[The immunomodulating action of interferon. The change in the rosette-forming activity of human blood lymphocytes under the influence of gamma-interferon and recombinant alpha 2-interferon]. Vestn Dermatol Venerol (1990) 0.78
[The respiratory rate of the pig]. Dtsch Tierarztl Wochenschr (1963) 0.77
[ Recommendations for the forensic and age determination from the skeleton]. Anthropol Anz (2005) 0.77
Anthropometrical measurements and androgen levels in males, females, and hormonally untreated female-to-male transsexuals. Arch Sex Behav (1997) 0.76
[On the chemical evaluation of the protein quality of food after proteolytic decomposition]. Z Ernahrungswiss (1969) 0.75
[Effect of the adjuvant on the process of antibody formation (immuno-fluorescent studies)]. Zh Mikrobiol Epidemiol Immunobiol (1965) 0.75
[Sensitizing activity of the components of diphtheria toxoid]. Zh Mikrobiol Epidemiol Immunobiol (1972) 0.75
[Cellular immunity in mice immunized with pertussis vaccine]. Zh Mikrobiol Epidemiol Immunobiol (1977) 0.75
[Effect of antileukocyte serums on heterogeneous cell populations]. Zh Mikrobiol Epidemiol Immunobiol (1971) 0.75
[Serotonin in human mast cells]. Arkh Patol (1969) 0.75
[Possibility of cytochemical detection of serotonin in human connective tissue cells]. Arkh Anat Gistol Embriol (1970) 0.75
[Characteristics of 2 types of antigen-binding T suppressors formed during an immune response using T-T hybridomas and their extracts]. Biull Eksp Biol Med (1986) 0.75
[Ultrafiltration characteristics of immunobiological preparations]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[Anti-infectious immunity, vaccination and histocompatibility antigens]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75
[Expression of the class II antigens of the major histocompatibility complex on the blood cells of psoriasis patients and its alteration under the influence of interferon preparations]. Vestn Dermatol Venerol (1989) 0.75
[Model of a stable form of delayed hypersensitivity to chemical allergens]. Biull Eksp Biol Med (1987) 0.75
Transfer factor therapy of thoracic sarcoidosis. Allergol Immunopathol (Madr) (1989) 0.75
[New principles and methods of designing immunobiological agents]. Vestn Ross Akad Med Nauk (1999) 0.75
[Immunologic characteristics of the thymus]. Vestn Akad Med Nauk SSSR (1971) 0.75
[Immunologic safety of vaccines]. Patol Fiziol Eksp Ter (1999) 0.75
[Cytokines in vaccines and interferon preparations]. Zh Mikrobiol Epidemiol Immunobiol (1997) 0.75
[Re-expression of the sheep red blood cell receptor--a diagnostic marker of cutaneous T-cell lymphomas?]. Dermatol Monatsschr (1989) 0.75
[Macrophage migration inhibition factor]. Usp Sovrem Biol (1978) 0.75
[The safety problems of new vaccines]. Vestn Ross Akad Med Nauk (1999) 0.75
Changes in content of nucleic acids during immunogenesis. Fed Proc Transl Suppl (1965) 0.75
[Inefficiency of synthetic phenolic antioxidants in rats with nephrotoxic nephritis]. Patol Fiziol Eksp Ter (1994) 0.75
[The improvement of the quality indices of tetanus anatoxin by using membrane partition]. Zh Mikrobiol Epidemiol Immunobiol (1994) 0.75
[Agglomeration test technic in the diagnosis of drug allergy]. Klin Med (Mosk) (1972) 0.75
[The phenomenon of leukocyte agglomeration in the diagnosis of drug allergy in patients with pulmonary tuberculosis]. Klin Med (Mosk) (1965) 0.75
[Possibilities of using Soviet-made semipermeable membranes for ultrafiltration of biological materials]. Lab Delo (1974) 0.75
[The use of the immunofluorescent method for the study of the formation of antibodies against pollen antigens]. Biull Eksp Biol Med (1965) 0.75
[The use of laboratory mice for the bacteriological diagnosis of tuberculosis]. Probl Tuberk (1972) 0.75
[Care of a child after cardiac surgery]. Kinderkrankenschwester (1994) 0.75
[Masugi's nephritis: preparation of an active nephrotoxic serum]. Biull Eksp Biol Med (1985) 0.75
[Effects of cytokines on the immunogenic properties of hepatitis A vaccine]. Vopr Virusol (2005) 0.75
Adult chronic granulomatosis disease-like neutrophil granulocyte disorder corrected by dialysable leukocyte extract. Allergol Immunopathol (Madr) (1988) 0.75
[Allergic alteration of the leukocytes in patients with pollenosis]. Biull Eksp Biol Med (1967) 0.75
[Electron microscopic study of diptheria toxin and anatoxin preparations]. Zh Mikrobiol Epidemiol Immunobiol (1974) 0.75
[Allergy and vaccination]. Patol Fiziol Eksp Ter (2009) 0.75
[New vaccines developed in the Russian Federation]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.75
[The immunomodulating action of interferon preparations. 3. Changes in the phagocytic activity of human blood neutrophilic granulocytes under the influence of interferon preparations]. Vestn Dermatol Venerol (1990) 0.75
[Delayed hypersensitivity to the antigens of the herpes simplex virus and herpetic resistance induced in mice by the administration of xenogeneic lymphocytic ultrafiltrates]. Zh Mikrobiol Epidemiol Immunobiol (1989) 0.75
[Experimental basis of a new principle for purifying antilymphocyte serum]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75
[The immunofluorescent method of detecting circulating antibodies in patients sensitive to plant pollen]. Zh Mikrobiol Epidemiol Immunobiol (1967) 0.75
[The effect of preparations of specific and nonspecific transfer-factor on the course of experimental tick-borne encephalitis]. Vopr Virusol (1990) 0.75
Immunofluorescent investigation of antibody formation in delayed hypersensitivity. Fed Proc Transl Suppl (1966) 0.75
[A macrophage migration-inhibiting factor in preparations of alpha- and gamma-interferon]. Vopr Virusol (1986) 0.75
[Participation of cellular immunity mediators in the development of anti-infection resistance]. Zh Mikrobiol Epidemiol Immunobiol (1978) 0.75
[Macrophage migration inhibition factor]. Usp Sovrem Biol (1978) 0.75
[Production of monospecific sera against human immunoglobulins]. Zh Mikrobiol Epidemiol Immunobiol (1971) 0.75
[Autoallergy in experimental myocardial infarct]. Vestn Akad Med Nauk SSSR (1967) 0.75
[Evans blue as an adjuvant for enhancing delayed hypersensitivity in an experiment]. Biull Eksp Biol Med (1985) 0.75
[Allergy to plant pollen]. Usp Sovrem Biol (1969) 0.75
[Comparative evaluation of methods of measuring the drug resistance of Mycobacterium tuberculosis]. Lab Delo (1965) 0.75
[Immunizing activity of diphtheria toxoid components]. Zh Mikrobiol Epidemiol Immunobiol (1972) 0.75
[Induction of T-suppressors of delayed-type hypersensitivity with a background of T-effector formation]. Biull Eksp Biol Med (1983) 0.75
[Effect of an extract from human tonsil lymphocytes on the macrophage migration inhibition reaction in guinea pigs upon contact with different antigens]. Biull Eksp Biol Med (1978) 0.75
[The local specific immune response to Staphylococcus aureus protein A in human tonsillar lymphoid tissue]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[Mechanism of the inhibition of proliferation of hapten-modified human and mouse leukemic cells by hapten-specific T-suppressor factor]. Biull Eksp Biol Med (1989) 0.75
Mitigating effects of dialysable leukocyte extract (DLE) on the experimental allergic uveitis (EAU) of the rabbit. Allergol Immunopathol (Madr) (1991) 0.75
[Antibody formation in the thymus and the development of delayed allergy following the introduction of an antigen into it]. Zh Mikrobiol Epidemiol Immunobiol (1969) 0.75
[Immunoenzyme analysis of the change in the expression of class II antigens of the major histocompatibility complex under the influence of interferon preparations]. Biull Eksp Biol Med (1989) 0.75
[The use of carboxymethylcellulose as a supporting medium in the local hemolysis reaction]. Lab Delo (1966) 0.75
[Disintegration of cellular material with the use of a high pressure press]. Lab Delo (1966) 0.75
[Antigenic differences in thymocytes and lymphocytes]. Biull Eksp Biol Med (1969) 0.75
[Sensitizing properties of tetanus toxoid fractions separated by ion-exchange chromatography]. Biull Eksp Biol Med (1972) 0.75
[I. I. Mechnikov's cellular theory of immunity and the concept of anti-infectious resistance]. Zh Mikrobiol Epidemiol Immunobiol (1995) 0.75
[Induction of macrophage migration inhibition factor-producing cells in vitro]. Biull Eksp Biol Med (1986) 0.75
["Transfer factor". Experimental findings and prospects for its clinical use]. Patol Fiziol Eksp Ter (1977) 0.75
[Lipid peroxidation in the kidneys of rats with nephritis induced by nephrotoxic serum and proteinuria induced by albumin overload]. Biull Eksp Biol Med (1991) 0.75
[Mixed water-oil--oil-water emulsion in the comparative evaluation of the adjuvant properties of bacteria in immunization with diphtheria anatoxin]. Zh Mikrobiol Epidemiol Immunobiol (1969) 0.75
[Removal of the antibodies to human serum proteins from antilymphocyte serum using an immunosorbent]. Zh Mikrobiol Epidemiol Immunobiol (1975) 0.75
[Leukocyte migration inhibiting factor in preparations of alpha and gamma interferons]. Vopr Virusol (1987) 0.75
[The immunomodulating action of interferon preparations. The effect of medicinal alpha-interferon preparations on the rosette-forming activity of human blood lymphocytes]. Vestn Dermatol Venerol (1990) 0.75